Cargando…
Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
Autores principales: | Bui, Ai-Tram N., Nelson, Caroline A., Lian, Christine G., Canales, Alvaro Laga, LeBoeuf, Nicole R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369459/ https://www.ncbi.nlm.nih.gov/pubmed/32715051 http://dx.doi.org/10.1016/j.jdcr.2020.04.010 |
Ejemplares similares
-
Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
por: Pabón-Cartagena, Gabriela, et al.
Publicado: (2020) -
Nivolumab-induced eosinophilic fasciitis: a case report
por: Ollier, Natasha, et al.
Publicado: (2020) -
Nivolumab-induced multiple morphea associated with eosinophilic fasciitis
por: Lacombe, Marouschka, et al.
Publicado: (2022) -
Eosinophilic fasciitis
por: Lamback, Elisa Baranski, et al.
Publicado: (2016) -
Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature
por: Iriarte, Christopher, et al.
Publicado: (2022)